Eloxx Pharmaceuticals, Inc. (ELOX)
NASDAQ: ELOX · Real-Time Price · USD
15.07
-0.93 (-5.81%)
At close: Aug 28, 2026, 4:00 PM EDT
15.36
+0.29 (1.92%)
After-hours: Aug 28, 2026, 7:53 PM EDT
Eloxx Pharmaceuticals Employees
Eloxx Pharmaceuticals had 10 employees as of December 31, 2025. The number of employees decreased by 8 or -44.44% compared to the previous year.
Employees
10
Change (1Y)
-8
Growth (1Y)
-44.44%
Revenue / Employee
n/a
Profits / Employee
-$1,065,100
Market Cap
60.83M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 10 | -8 | -44.44% |
| Dec 31, 2022 | 18 | -10 | -35.71% |
| Dec 31, 2021 | 28 | 3 | 12.00% |
| Dec 31, 2020 | 25 | -4 | -13.79% |
| Dec 31, 2019 | 29 | 0 | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Heron Therapeutics | 128 |
| Alps Group | 93 |
| Xilio Therapeutics | 76 |
| Boundless Bio | 28 |
| INmune Bio | 21 |
| ImageneBio | 18 |
| Edesa Biotech | 17 |
| Serina Therapeutics | 16 |
ELOX News
- 10 days ago - Eloxx Pharmaceuticals initiated with a Buy at Lucid Capital - TheFly
- 18 days ago - Eloxx Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update - PRNewsWire
- 19 days ago - Eloxx Pharmaceuticals Quarterly report: Q2 2026 - Filings
- 19 days ago - Eloxx Pharmaceuticals Earnings release: Q2 2026 - Filings
- 5 weeks ago - Eloxx Pharmaceuticals initiated with an Outperform at LifeSci Capital - TheFly
- 5 weeks ago - Eloxx Pharmaceuticals initiated with a Buy at Guggenheim - TheFly
- 6 weeks ago - Eloxx Pharmaceuticals initiated with a Buy at Guggenheim - TheFly
- 7 weeks ago - Eloxx Pharmaceuticals Inc trading resumes - TheFly